Stock Track | Rapid7 Plummets 5.10% as Multiple Analysts Slash Price Targets

Stock Track
Aug 08, 2025

Shares of Rapid7 (RPD) plummeted 5.10% in pre-market trading on Friday, as several prominent analysts cut their price targets for the cybersecurity firm following its recent earnings report. The wave of downgrades has sparked concerns among investors about the company's near-term growth prospects and strategic direction.

Leading financial institutions, including UBS, Raymond James, and Stifel, have significantly reduced their price targets for Rapid7. UBS lowered its target from $39 to $34, while Raymond James cut its projection from $40 to $30. Stifel made one of the most substantial reductions, slashing its target price from $29 to $22. These downgrades reflect growing skepticism about Rapid7's ability to meet market expectations in the coming quarters.

The series of price target cuts comes in the wake of Rapid7's latest earnings report, which, despite beating expectations with adjusted earnings of $0.56 per share compared to the anticipated $0.44, failed to impress analysts. Market watchers appear concerned about the company's strategic shift and potential execution risks. Needham analyst Mike Cikos maintained a Hold rating on the stock, citing caution about the company's ongoing transitions. As Rapid7 navigates these challenges, investors will be closely watching for signs of improved performance and strategic clarity in the coming months.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10